• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
News and impact
NIHR Biomedical Research Centre Leicester

NIHR Biomedical Research Centre Leicester

  • Home
  • About Us
    • Leadership Team
    • Our Impact
    • Our NIHR infrastructure
    • Governance
    • Inclusion
    • Strategies
    • Contact us
  • Our Research
    • Our Impact
    • Spotlight on our researchers
    • Cardiovascular
    • Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health
    • Environment
    • Lifestyle
    • Personalised Cancer Prevention and Treatment
    • Respiratory and Infection
  • Patients and Public
    • Get Involved
    • Upcoming Public Involvement opportunities
    • Our approach to Public Involvement
    • Join the BioResource and Be Part of Research
    • Taking part in Clinical Trials
  • Industry and Partners
    • What we offer to industry
    • Collaborate with the Leicester BRC
    • Our partnerships
      • The NIHR Diet and Activity Research Translation (DART) Collaboration
  • For Researchers
    • Training
    • The Internal Resource Hub
    • Acknowledging and communicating your research
    • Guidance on Public Involvement (PPIE) for researchers
    • Advancing inclusion: transforming research culture in Leicester and beyond
    • PPI for Statistical Methodology and Research Techniques
  • News and Impact

Research in Leicester could help detect early signs of heart failure in diabetic patients

Oct 6, 2021

New research in Leicester, which has been funded by the British Heart Foundation (BHF), could help understand how heart failure can develop in people living with Type 2 diabetes.

An estimated 3.7 million people in the UK are diagnosed with Type 2 diabetes. The condition is a significant risk factor for heart disease, as it causes damage to the blood vessels. This can lead to heart failure, which means the heart can’t pump blood around the body as well as it should.

Currently, it is unknown how many people with Type 2 diabetes develop heart failure, why they are particularly at risk of developing it – and how to detect a decline in heart function earlier.

A previous small study found that in diabetic patients, their heart has an abnormal way of using the calcium that is needed to make heart muscle cells contract and deliver blood around the body.

Now, researchers at the University of Leicester have been awarded £275,000 from the BHF to carry out a larger study to understand if this abnormal handling of calcium in the heart could lead to heart failure.

The project will involve using MRI scans to study the hearts of 60 people with Type 2 diabetes but without any previous evidence of heart failure. These scans will help visualise how calcium is handled in their heart.

MRI scans will also be carried out on 20 people with diabetes and heart failure and a further 20 healthy volunteers, so that the results can be compared. The research will identify the characteristics of heart failure in diabetic patients.

Alongside this, 40 adults aged under 40 with Type 2 diabetes will be studied over six months undertaking a low-calorie diet and exercise training. This will assess the impact on the heart and see if it can lead to diabetes remission and improved heart function.

The funding has been awarded to Gerry McCann, Professor of Cardiac Imaging at University of Leicester and Honorary Consultant Cardiologist at Leicester’s Hospitals. The project will be led by Dr Abhishek Dattani.

Professor McCann said: “Heart failure is a major cause of reduced quality of life and life expectancy in people with diabetes.

“Detecting signs of heart deterioration earlier in these patients means we can diagnose them quicker and provide treatments sooner.

“This study adds to the cutting edge research we are doing with the Leicester Diabetes Centre. The results should give us a better understanding of heart disease in patients with diabetes and potentially lead to new ways of diagnosing the condition, as well as new treatments.”

Dr Gabriela Warpsinski, Research Advisor at the BHF, added: “In the UK, one third of adults with diabetes sadly die from a heart or circulatory disease, so finding early treatments and preventions is key.

“This study will identify the abnormal changes that happen in the heart of diabetics and how these changes can progress to heart failure, which could ultimately reveal new targets to prevent or treat heart failure in people living with diabetes.

“The BHF can only fund vital research like this thanks to the generous support of the public, in driving forward our mission to beat heartbreak forever.”

Ends

Category: Press ReleasesTag: cardiovascular, diabetes, News, Press Release

Sidebar

Recent News

New name and identity for a service dedicated to involving patients and the public in vascular research

East Midlands celebration highlights the power of research collaboration

Tozorakimab demonstrated statistically significant and highly clinically meaningful reduction in COPD exacerbations trials

Read more news stories

The NIHR Leicester BRC is part of the NIHR and hosted by the University Hospitals of Leicester NHS Trust in partnership with the University of Leicester,  Loughborough University and the University Hospitals of the Northamptonshire NHS Group.

Get in touch

NIHR Leicester Biomedical Research Centre

University Hospitals of Leicester NHS Trust
Research & Innovation
Leicester General Hospital
Gwendolen Road
Leicester, LE5 4PW

Contact us

Our Research

Spotlight on our researchers

Cardiovascular

Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health

Environment

Personalised Cancer Prevention and Treatment

Lifestyle

Respiratory and Infection

About BRC

Our NIHR infrastructure

BRC clinical research during COVID-19

Our 2022 – 2028 strategy documents

Governance

Useful links

Our partnerships

Inclusion

Privacy notice

Cookie Policy

Copyright © NIHR Biomedical Research Centre: Leicester

  • LinkedIn
  • X
  • Facebook
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}